Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

MKK3 sustains cell proliferation and survival through p38DELTA MAPK activation in colorectal cancer.

Stramucci L, Pranteda A, Stravato A, Amoreo CA, Pennetti A, Diodoro MG, Bartolazzi A, Milella M, Bossi G.

Cell Death Dis. 2019 Nov 6;10(11):842. doi: 10.1038/s41419-019-2083-2.

2.

Scientific leadership: the Italian Government's perspective.

Sciacchitano S, Bartolazzi A, Grillo G.

Lancet. 2019 Aug 17;394(10198):562-563. doi: 10.1016/S0140-6736(19)30496-9. No abstract available.

PMID:
31423994
3.

Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy: The Galectin-3 Signature in NSCLCs.

Capalbo C, Scafetta G, Filetti M, Marchetti P, Bartolazzi A.

Int J Mol Sci. 2019 Mar 31;20(7). pii: E1607. doi: 10.3390/ijms20071607.

4.

Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma.

Pisanu ME, Maugeri-Saccà M, Fattore L, Bruschini S, De Vitis C, Tabbì E, Bellei B, Migliano E, Kovacs D, Camera E, Picardo M, Jakopin Z, Cippitelli C, Bartolazzi A, Raffa S, Torrisi MR, Fulciniti F, Ascierto PA, Ciliberto G, Mancini R.

J Exp Clin Cancer Res. 2018 Dec 17;37(1):318. doi: 10.1186/s13046-018-0989-7.

5.

Galectin-3 Targeting in Thyroid Orthotopic Tumors Opens New Ways to Characterize Thyroid Cancer.

De Rose F, Braeuer M, Braesch-Andersen S, Otto AM, Steiger K, Reder S, Mall S, Nekolla S, Schwaiger M, Weber WA, Bartolazzi A, D'Alessandria C.

J Nucl Med. 2019 Jun;60(6):770-776. doi: 10.2967/jnumed.118.219105. Epub 2018 Oct 25.

PMID:
30361380
6.

A "seasonal bromoderma" in a farmer.

Pranteda G, Magri F, Muscianese M, D'Arino A, Pranteda G, Fidanza L, Bartolazzi A.

Dermatol Ther. 2019 Jan;32(1):e12764. doi: 10.1111/dth.12764. Epub 2018 Oct 21.

PMID:
30288911
7.

Galectins in Cancer and Translational Medicine: From Bench to Bedside.

Bartolazzi A.

Int J Mol Sci. 2018 Sep 27;19(10). pii: E2934. doi: 10.3390/ijms19102934. No abstract available.

8.

The management of pseudomyogenic hemangioendothelioma of the foot: A case report and review of the literature.

Pranteda G, Magri F, Muscianese M, Pigliacelli F, D'Arino A, Federico A, Pranteda G, Bartolazzi A.

Dermatol Ther. 2018 Nov;31(6):e12725. doi: 10.1111/dth.12725. Epub 2018 Sep 21. Review.

PMID:
30239066
9.

MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors.

Petroni M, Sardina F, Infante P, Bartolazzi A, Locatelli E, Fabretti F, Di Giulio S, Capalbo C, Cardinali B, Coppa A, Tessitore A, Colicchia V, Sahùn Roncero M, Belardinilli F, Di Marcotullio L, Soddu S, Comes Franchini M, Petricci E, Gulino A, Giannini G.

Cell Death Dis. 2018 Aug 30;9(9):895. doi: 10.1038/s41419-018-0924-z.

10.

Mice with reduced expression of the telomere-associated protein Ft1 develop p53-sensitive progeroid traits.

La Torre M, Merigliano C, Burla R, Mottini C, Zanetti G, Del Giudice S, Carcuro M, Virdia I, Bucciarelli E, Manni I, Vinciguerra GR, Piaggio G, Riminucci M, Cumano A, Bartolazzi A, Vernì F, Soddu S, Gatti M, Saggio I.

Aging Cell. 2018 Aug;17(4):e12730. doi: 10.1111/acel.12730. Epub 2018 Apr 10.

11.

Loss of miR-204 expression is a key event in melanoma.

Galasso M, Morrison C, Minotti L, Corrà F, Zerbinati C, Agnoletto C, Baldassari F, Fassan M, Bartolazzi A, Vecchione A, Nuovo GJ, Di Leva G, D'Atri S, Alvino E, Previati M, Nickoloff BJ, Croce CM, Volinia S.

Mol Cancer. 2018 Mar 9;17(1):71. doi: 10.1186/s12943-018-0819-8.

12.

25-Hydroxyvitamin D serum levels and melanoma risk: a case-control study and evidence synthesis of clinical epidemiological studies.

Cattaruzza MS, Pisani D, Fidanza L, Gandini S, Marmo G, Narcisi A, Bartolazzi A, Carlesimo M.

Eur J Cancer Prev. 2019 May;28(3):203-211. doi: 10.1097/CEJ.0000000000000437.

PMID:
29438161
13.

Galectin-3 is essential for proper bone cell differentiation and activity, bone remodeling and biomechanical competence in mice.

Iacobini C, Blasetti Fantauzzi C, Bedini R, Pecci R, Bartolazzi A, Amadio B, Pesce C, Pugliese G, Menini S.

Metabolism. 2018 Jun;83:149-158. doi: 10.1016/j.metabol.2018.02.001. Epub 2018 Feb 9.

PMID:
29432728
14.

Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives.

Bartolazzi A, Sciacchitano S, D'Alessandria C.

Int J Mol Sci. 2018 Feb 2;19(2). pii: E445. doi: 10.3390/ijms19020445. Review.

15.

Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families.

Coppa A, Nicolussi A, D'Inzeo S, Capalbo C, Belardinilli F, Colicchia V, Petroni M, Zani M, Ferraro S, Rinaldi C, Buffone A, Bartolazzi A, Screpanti I, Ottini L, Giannini G.

Cancer Med. 2018 Jan;7(1):46-55. doi: 10.1002/cam4.1251. Epub 2017 Dec 22.

16.

Case report: skin injury after contact with a red spine starfish, Protoreaster lincki.

Tammaro A, Palumbo A, Bommarito C, Pepe G, Romano I, Parisella FR, Persechino S, Bartolazzi A.

Contact Dermatitis. 2018 Jan;78(1):95-96. doi: 10.1111/cod.12865. No abstract available.

PMID:
29265447
17.

Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology.

Sciacchitano S, Lavra L, Ulivieri A, Magi F, De Francesco GP, Bellotti C, Salehi LB, Trovato M, Drago C, Bartolazzi A.

Oncotarget. 2017 Jul 25;8(30):49421-49442. doi: 10.18632/oncotarget.17220. Review.

18.

Oncocytic Variant of Medullary Thyroid Carcinoma: A Rare Case of Sporadic Multifocal and Bilateral RET Wild-Type Neoplasm with Revision of the Literature.

Vinciguerra GL, Noccioli N, Cippitelli C, Minucci A, Capoluongo E, Bartolazzi A.

Rare Tumors. 2016 Dec 20;8(4):6537. doi: 10.4081/rt.2016.6537. eCollection 2016 Nov 17.

19.

Diffuse Follicular Variant of Papillary Thyroid Carcinoma: A Case Report with a Revision of Literature.

Vinciguerra GL, Noccioli N, Bartolazzi A.

Rare Tumors. 2016 Dec 20;8(4):6536. doi: 10.4081/rt.2016.6536. eCollection 2016 Nov 17.

20.

Antiproliferative Effects of 1α-OH-vitD3 in Malignant Melanoma: Potential Therapeutic implications.

Spath L, Ulivieri A, Lavra L, Fidanza L, Carlesimo M, Giubettini M, Narcisi A, Luciani E, Bucci B, Pisani D, Sciacchitano S, Bartolazzi A.

Sci Rep. 2017 Jan 11;7:40370. doi: 10.1038/srep40370.

21.

Combined clinical and ultrasound follow-up assists in malignancy detection in Galectin-3 negative Thy-3 thyroid nodules.

Sciacchitano S, Lavra L, Ulivieri A, Magi F, Porcelli T, Amendola S, De Francesco GP, Bellotti C, Trovato MC, Salehi LB, Bartolazzi A.

Endocrine. 2016 Oct;54(1):139-147. Epub 2015 Oct 16.

PMID:
26475496
22.

Noninvasive In Vivo Imaging and Biologic Characterization of Thyroid Tumors by ImmunoPET Targeting of Galectin-3.

D'Alessandria C, Braesch-Andersen S, Bejo K, Reder S, Blechert B, Schwaiger M, Bartolazzi A.

Cancer Res. 2016 Jun 15;76(12):3583-92. doi: 10.1158/0008-5472.CAN-15-3046. Epub 2016 May 23. Erratum in: Cancer Res. 2017 Aug 1;77(15):4204.

23.

A Case of Sinonasal Melanoma With Unusual Primary Exon 17 KIT D820G Mutation.

Pilozzi E, Bartolazzi A, Fochetti F, Duranti E, Scarpino S, Valeriani M, Moriconi P, Ruco L.

Appl Immunohistochem Mol Morphol. 2016 Nov/Dec;24(10):e94-e97.

PMID:
27153441
24.

Investigation of VOCs associated with different characteristics of breast cancer cells.

Lavra L, Catini A, Ulivieri A, Capuano R, Baghernajad Salehi L, Sciacchitano S, Bartolazzi A, Nardis S, Paolesse R, Martinelli E, Di Natale C.

Sci Rep. 2015 Aug 25;5:13246. doi: 10.1038/srep13246.

25.

Nodular Lymphocyte-Predominant Hodgkin Lymphoma in a Warthin Tumor of the Parotid Gland: A Case Report and Literature Review.

Di Napoli A, Mallel G, Bartolazzi A, Cavalieri E, Becelli R, Cippitelli C, Ruco L.

Int J Surg Pathol. 2015 Aug;23(5):419-23. doi: 10.1177/1066896915582263. Review.

PMID:
26169920
26.

HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicity.

Valente D, Bossi G, Moncada A, Tornincasa M, Indelicato S, Piscuoglio S, Karamitopoulou ED, Bartolazzi A, Pierantoni GM, Fusco A, Soddu S, Rinaldo C.

Oncotarget. 2015 Apr 30;6(12):10320-34.

27.

Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.

Veschi V, Petroni M, Bartolazzi A, Altavista P, Dominici C, Capalbo C, Boldrini R, Castellano A, McDowell HP, Pizer B, Frati L, Screpanti I, Gulino A, Giannini G.

Cell Death Dis. 2014 Mar 6;5:e1100. doi: 10.1038/cddis.2014.68.

28.

Primary thyroid paraganglioma: a rare entity affecting middle-aged women.

D'Angelo FA, Antolino L, Magistri P, Giubettini M, Aurello P, Maceli F, Bollanti L, Bartolazzi A, Ramacciato G.

Am Surg. 2013 Dec;79(12):E351-3. No abstract available.

PMID:
24351342
29.

A very unusual thyroid tumor: a nodule with mature fat papillary hyperplasia and focal atypia.

Cacchi C, M Arnholdt H, Bartolazzi A.

Rare Tumors. 2013 Sep 30;5(3):e50. doi: 10.4081/rt.2013.e50. eCollection 2013.

30.

Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells.

Paroli M, Bellati F, Videtta M, Focaccetti C, Mancone C, Donato T, Antonilli M, Perniola G, Accapezzato D, Napoletano C, Nuti M, Bartolazzi A, Panici PB, Tripodi M, Palombo F, Barnaba V.

Int J Cancer. 2014 Apr 15;134(8):1823-34. doi: 10.1002/ijc.28515. Epub 2013 Oct 22. Erratum in: Int J Cancer. 2014 Jul 15;135(2):E1.

31.

A case of subacute cutaneous lupus erythematosus in a patient with mixed connective tissue disease: successful treatment with plasmapheresis and rituximab.

Fantò M, Salemi S, Socciarelli F, Bartolazzi A, Natale GA, Casorelli I, Pavan A, Vaglio S, Di Rosa R, D'Amelio R.

Case Rep Rheumatol. 2013;2013:857694. doi: 10.1155/2013/857694. Epub 2013 Jul 28.

32.

Schwannoma-like pleomorphic adenoma: a case report with review of the literature.

Lombardi M, Socciarelli F, Fini G, Leonardi A, Bartolazzi A.

Head Neck Pathol. 2014 Jun;8(2):178-81. doi: 10.1007/s12105-013-0473-9. Epub 2013 Jul 10. Review.

33.

Debating the presentation, morphology, origin, and prognosis of a combined hepatocellular-cholangiocarcinoma.

Lorenzon L, Castaldo P, Bartolazzi A, Rossi Del Monte S, Camboni A, Pilozzi E, Salvi PF, Ziparo V.

Dig Dis Sci. 2013 Aug;58(8):2423-4. doi: 10.1007/s10620-013-2720-z. Epub 2013 May 22. No abstract available. Erratum in: Dig Dis Sci. 2013 Sep;58(9):2742. Salvi, Pierfederico [corrected to Salvi, Pier Federico].

PMID:
23695879
34.

Renal cell carcinoma diagnosed by cutaneous metastasis: a case report.

Carlesimo M, Abruzzese C, Narcisi A, Arcese A, Cortesi G, Di Russo PP, Fidanza L, Feliziani G, Gargano C, Bartolazzi A, Camplone G.

Cutis. 2012 Oct;90(4):196-9.

PMID:
23259207
35.

Galectin-3 impairment of MYCN-dependent apoptosis-sensitive phenotype is antagonized by nutlin-3 in neuroblastoma cells.

Veschi V, Petroni M, Cardinali B, Dominici C, Screpanti I, Frati L, Bartolazzi A, Gulino A, Giannini G.

PLoS One. 2012;7(11):e49139. doi: 10.1371/journal.pone.0049139. Epub 2012 Nov 9.

36.

Homeodomain-interacting protein kinase2 in human idiopathic pulmonary fibrosis.

Ricci A, Cherubini E, Ulivieri A, Lavra L, Sciacchitano S, Scozzi D, Mancini R, Ciliberto G, Bartolazzi A, Bruno P, Graziano P, Mariotta S.

J Cell Physiol. 2013 Jan;228(1):235-41. doi: 10.1002/jcp.24129.

PMID:
22689412
37.

HIPK2 controls cytokinesis and prevents tetraploidization by phosphorylating histone H2B at the midbody.

Rinaldo C, Moncada A, Gradi A, Ciuffini L, D'Eliseo D, Siepi F, Prodosmo A, Giorgi A, Pierantoni GM, Trapasso F, Guarguaglini G, Bartolazzi A, Cundari E, Schininà ME, Fusco A, Soddu S.

Mol Cell. 2012 Jul 13;47(1):87-98. doi: 10.1016/j.molcel.2012.04.029. Epub 2012 May 31.

38.

Efficacy of acitretin in the treatment of squamous cell carcinoma of the oral cavity.

Carlesimo M, Narcisi A, Abruzzese C, Orsini D, Cortesi G, Arcese A, Bartolazzi A, Camplone G.

Eur J Cancer Prev. 2011 Sep;20(5):429-30. doi: 10.1097/CEJ0b013e3283481ddc. No abstract available.

PMID:
21799337
39.

The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas.

Lavra L, Rinaldo C, Ulivieri A, Luciani E, Fidanza P, Giacomelli L, Bellotti C, Ricci A, Trovato M, Soddu S, Bartolazzi A, Sciacchitano S.

PLoS One. 2011;6(6):e20665. doi: 10.1371/journal.pone.0020665. Epub 2011 Jun 17.

40.

Methodology and technical requirements of the galectin-3 test for the preoperative characterization of thyroid nodules.

Bartolazzi A, Bellotti C, Sciacchitano S.

Appl Immunohistochem Mol Morphol. 2012 Jan;20(1):2-7. doi: 10.1097/PAI.0b013e31821ee9bb. Review.

PMID:
21691201
41.

HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage.

Lazzari C, Prodosmo A, Siepi F, Rinaldo C, Galli F, Gentileschi M, Bartolazzi A, Costanzo A, Sacchi A, Guerrini L, Soddu S.

Oncogene. 2011 Dec 1;30(48):4802-13. doi: 10.1038/onc.2011.182. Epub 2011 May 23.

PMID:
21602882
42.

A primary cutaneous adenoid-cystic carcinoma in a young woman. Differential diagnosis and clinical implications.

Cacchi C, Persechino S, Fidanza L, Bartolazzi A.

Rare Tumors. 2011 Mar 30;3(1):e3. doi: 10.4081/rt.2011.e3.

43.

MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response.

Petroni M, Veschi V, Prodosmo A, Rinaldo C, Massimi I, Carbonari M, Dominici C, McDowell HP, Rinaldi C, Screpanti I, Frati L, Bartolazzi A, Gulino A, Soddu S, Giannini G.

Mol Cancer Res. 2011 Jan;9(1):67-77. doi: 10.1158/1541-7786.MCR-10-0227. Epub 2010 Dec 20.

44.

Hyperbaric oxygen therapy in a case of cholesterol crystal embolization.

Gurgo A, Valenti V, Paneni F, Passerini J, Di Vavo M, Calvieri C, Cacchi C, Bartolazzi A, Sabani A, Volpe M.

Am J Emerg Med. 2011 Jul;29(6):694.e3-6. doi: 10.1016/j.ajem.2010.05.023. Epub 2010 Aug 13. No abstract available.

PMID:
20708883
45.

Primary cutaneous Hodgkin lymphoma.

Pranteda G, Osti MF, Cox MC, Cacchi C, Carlesimo M, Grimaldi M, Fidanza L, Bartolazzi A.

J Am Acad Dermatol. 2010 Aug;63(2):e52-3. doi: 10.1016/j.jaad.2009.06.076. No abstract available.

PMID:
20633790
46.

Galectin-3 detection on large-needle aspiration biopsy improves preoperative selection of thyroid nodules: a prospective cohort study.

Carpi A, Rossi G, Coscio GD, Iervasi G, Nicolini A, Carpi F, Mechanick JI, Bartolazzi A.

Ann Med. 2010;42(1):70-8. doi: 10.3109/07853890903439778.

PMID:
20001505
47.

HIPK2 is involved in cell proliferation and its suppression promotes growth arrest independently of DNA damage.

Iacovelli S, Ciuffini L, Lazzari C, Bracaglia G, Rinaldo C, Prodosmo A, Bartolazzi A, Sacchi A, Soddu S.

Cell Prolif. 2009 Jun;42(3):373-84. doi: 10.1111/j.1365-2184.2009.00601.x. Epub 2009 Mar 31.

PMID:
19438900
48.

Rectal and gynecologic amputation for a giant eccrine porocarcinoma of the pelvic floor.

Salvi PF, Santanelli F, Ferri M, Dente M, Paolini G, Bartolazzi A, Iannicelli E, Ziparo V.

Am Surg. 2009 Mar;75(3):269-72. No abstract available.

PMID:
19350871
49.

Gal-3 is stimulated by gain-of-function p53 mutations and modulates chemoresistance in anaplastic thyroid carcinomas.

Lavra L, Ulivieri A, Rinaldo C, Dominici R, Volante M, Luciani E, Bartolazzi A, Frasca F, Soddu S, Sciacchitano S.

J Pathol. 2009 May;218(1):66-75. doi: 10.1002/path.2510.

PMID:
19199318
50.

Wells Syndrome with Multiorgan Involvement Mimicking Hypereosinophilic Syndrome.

Carlesimo M, Fidanza L, Mari E, Feliziani G, Narcisi A, De Marco G, Bartolazzi A, Camplone G.

Case Rep Dermatol. 2009 Sep 12;1(1):44-48.

Supplemental Content

Loading ...
Support Center